Company intelligence / Profile preview
Next Innovative Therapeutics
São Paulo, São Paulo, Brazilnintx.com.br ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Nintx is a Brazilian biotech leveraging proprietary simulation and data analytics platforms to discover multi-target therapies based on Brazil’s biodiversity. It focuses on multifactorial diseases with a strong emphasis on gut microbiome-mediated mechanisms. As of December 2024, it has raised $10 million Series A funding to accelerate R&D across eight new drug programs in partnership with industry and academic collaborators. All programs are preclinical; none have reached IND or clinical trial stage yet. The business model centers around outlicensing candidates post-preclinical development.
- Therapeutic areas
- OtherMetabolic Disorders
- Modalities
- Multi-target therapies derived from natural products, especially plant-based compounds from Brazilian biodiversity.Focus on multi-target approaches for multifactorial diseases, including those mediated by the human gut microbiome.
- Industry
- Biotech
02
Drug pipeline
15 assets14 more assets in the full pipeline.
03
Partnerships
Adeste (industry partner)Centroflora (industry partner)CIEnPCNPEM/Sirius particle accelerator facility (academic/research partners)Tiaraju (strategic investor/partner)
Beyond the preview
Go deeper on Next Innovative Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Next Innovative Therapeutics.